RÉCEPTEUR D'ANTIGÈNE CHIMÉRIQUE, ACIDE NUCLÉIQUE, PLASMIDE D'EXPRESSION DE RÉCEPTEUR D'ANTIGÈNE CHIMÉRIQUE, CELLULES EXPRIMANT LE RÉCEPTEUR D'ANTIGÈNE CHIMÉRIQUE, SON UTILISATION ET COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DU CANCER
The present disclosure relates to a chimeric antigen receptor, a nucleic acid, a chimeric antigen receptor expression plasmid, a chimeric antigen receptor expressing cell, a pharmaceutical composition for treating cancer, and use of the chimeric antigen receptor expressing cell. The chimeric antigen receptor is specific to human leukocyte antigen G. The nucleic acid encodes the chimeric antigen receptor. The chimeric antigen receptor expression plasmid expresses the chimeric antigen receptor. The chimeric antigen receptor expressing cell is obtained by transducing the chimeric antigen receptor into an immune cell. The pharmaceutical composition for treating cancer includes the chimeric antigen receptor expressing cell and a pharmaceutically acceptable carrier.
